Eterna Therapeutics Inc. (ERNA)
Market Open
11 Aug, 17:45
NASDAQ (CM) NASDAQ (CM) Primary $
4. 46
-0.07
-1.5453%
$
1.32M Market Cap
- P/E Ratio
- Div Yield
37,174 Volume
0 Eps
$ 4.53
Previous Close Want to track ERNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eterna Therapeutics Inc. (ERNA) Statistics
Valuation metrics
Market Cap 1.32M
Enterprise value -3.36M
Trailing P/E (ttm) -0.22
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 1.56
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 47.68K
Average volume (90 days) 864.5K
Price summary
52-Week low 3.18
52-Week high 71.5
Beta -
50-Day moving average 5.36
200-Day moving average 8.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 4 May 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.94%
Return on equity -3.06%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -10.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 2.01%
Book value per share (mrq) 2.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
